A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

Clinical trial NCT06298058 · RECRUITING

Trial details

NCT number: NCT06298058
Sponsor: Shanghai Institute Of Biological Products
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-05-09
Primary completion: 2026-04-30
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.